64859 event 1299676970 1475891670 This half day program will open with a keynote address from Dr. David Stephens, Vice President of Research for the Woodruff Health Sciences Center of Emory University and Principal Investigator of the Atlanta Clinical & Translational Science Institute (ACTSI), focusing on an overview of challenges involving clinical studies.  The keynote will be followed by two panel sessions; the first exploring the use of biomarkers to identify patient populations before clinical trials begin, and the second, employing advances in data management to assess outcomes of clinical trials.  

OTHER SPEAKERS:
    •    Mark Braunstein, MD, Associate Director, Health Systems Institute, Georgia Tech
    •    Scott Capps, Vice President Clinical Research, CryoLife
    •    Albert E. Heacox, Ph.D. Senior Vice President, Research and Development, CryoLife
    •    Joseph E. Martinez, Director of Research and Laboratory Services, FlowApps
    •    Robert T. McNally, Ph.D., President & CEO, Geovax, Inc.
    •    Ruth O' Regan, MD Director, Translational Breast Cancer Research, The Emory Clinic
    •    Joel Saltz, M.D., Ph.D., Director, Center for Comprehensive Informatics, Emory University
    •    Sandy Weinberg, Ph.D., Associate Professor of Healthcare Management, Clayton State University
The program will conclude with an Open Discussion moderated byMargaret K. Offermann, MD, Ph.D., Vice President-Elect for Science Policy, Federation of American Societies for Experimental Biology & Treasurer, Georgia Center for Oncology Research & Education.

A networking reception will end the day.

 

]]> This half day program will focus on an overview of challenges involving clinical studies.

]]> http://www.gabio.org/ 1292 1789 12335 12334 5815